Eiko Yamamoto

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

Kazuhiko Ino, Norio Yoshida, Hiroaki Kajiyama et al. · British Journal of Cancer · 2006 · 254 citations · Full text

Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival

Kazuhiko Ino, Eiko Yamamoto, Kiyosumi Shibata et al. · Clinical Cancer Research · 2008 · 231 citations · Full text

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi et al. · Leukemia · 2014 · 228 citations

Hematological Malignancy, Prognostic Impacts, Genetics +13

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

Tomoko Inaba, Kazuhiko Ino, Hiroaki Kajiyama et al. · Gynecologic Oncology · 2009 · 210 citations

Immunosuppressive Enzyme, Oncogenic Agent, Medicine +10

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

Kazuhiko Ino, Kiyosumi Shibata, Hiroaki Kajiyama et al. · British Journal of Cancer · 2006 · 125 citations · Full text